clinical pathways

From the Field

Facilitating Physician Adherence to Clinical Pathways Across a Multi-Site Oncology Practice Network

02/16/2016

Brian J Gebhardt, MD

Sushil Beriwal, MD

Dwight E Heron, MD, MBA, FACRO, FACR

Abstract: With so many new developments in the field on oncology, physicians have a difficult time staying abreast of new guidelines and recommendations for different disease states. Clinical pathways are an...

...

02/16/2016

Journal of Clinical Pathways

Clinical Pathways GPS

The Role of Patient Adherence in Successful Clinical Pathway Implementation

02/16/2016

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Scott Guerin, PhD

When considering the development of clinical pathways, the pathway itself is only the beginning; optimum outcomes cannot be realized unless patients follow their prescribed treatments. Simply having prescribers write...

When...

02/16/2016

Journal of Clinical Pathways

Research in Review

Critical Success Factors for Clinical Pathway Implementation Identified

02/16/2016

JCP Editors

Despite research supporting the usefulness of clinical pathways for reducing the variability of care in clinical practice, a large percentage of clinical pathway initiatives have been unsuccessful. In a new report,...

...

02/16/2016

Journal of Clinical Pathways

Research in Review

Clinical Pathways for Breast, Colon, and Rectal Cancers Improve Physician Adherence to Best Practices

02/16/2016

JCP Editors

Implementation of clinical pathways for breast, colon, and rectal cancers can help narrow the gap between evidence-based treatment guidelines and clinical practice, according to a new study.  With research on...

...

02/16/2016

Journal of Clinical Pathways

Clinical Pathways GPS

The Place for Biosimilars in Clinical Pathways

12/14/2015

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Scott Guerin, PhD

Payers and at-risk providers are developing clinical pathways with great specificity regarding the preferred drugs that be used. Increasingly, these pathways will include biosimilar products. There are three major...

Payers...

12/14/2015

Journal of Clinical Pathways

Interview

A Clinical Pathway for Transcatheter Aortic Valve Replacement

12/14/2015

More and more, various health care institutions around the country are implementing clinical pathways in an effort to improve outcomes and control costs. A 2003 study reported that more than 80% of hospitals had implemented clinical...

More and more, various...

12/14/2015

Journal of Clinical Pathways

Interview

Evidence Blocks to Evaluate the Relative Value of Oncology Treatments

12/14/2015

Many institutions and health care professionals have been aware of the staggering rise of health care costs. An IMS Health report published in May of 2015 confirmed that drug sales in the United States surpassed $100...

Many...

12/14/2015

Journal of Clinical Pathways

Feature

The Evolution of Clinical Pathways for Oncology

10/27/2015

Winston Wong, PharmD, Editor-in-Chief

Abstract: A substantial portion of total medication costs is represented by the cost of specialty drugs, which only continues to rise. Oncology, in particular, is one of the three most costly specialty therapeutic...

...

10/27/2015

Journal of Clinical Pathways